Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	COVID-19: Daily Top 10 Papers

Lung Cancer

Free Subscription Articles published in Eur J Cardiothorac Surg Retrieve available abstracts of 90 articles: HTML format

Single Articles

January 2022
1. ZHANG C, Li J, Sun H, Liu H, et al
   An aberrant anterior ascending segmental pulmonary artery (A3aii) in a patient with lung cancer.
   Eur J Cardiothorac Surg. 2022 Jan 8. pii: 6501291. doi: 10.1093.
   PubMed     Abstract available
   
   
   November 2021
2. DRAWBERT HE, Hey MT, Tarrazzi F, Block M, et al
   Early discharge on postoperative day 1 following lobectomy for stage I non-small-cell lung cancer is safe in high-volume surgical centres: a national cancer database analysis.
   Eur J Cardiothorac Surg. 2021 Nov 29. pii: 6445266. doi: 10.1093.
   PubMed     Abstract available
   
   
   
3. WANG Y, Zhong C, Fang W
   Thoracoscopic segmentectomy for early-stage non-small cell lung cancer: are we doing the right thing for our patients?
   Eur J Cardiothorac Surg. 2021 Nov 11. pii: 6425615. doi: 10.1093.
   PubMed    
   
   
   
4. MATSUGUMA H, Hasumi K, Wakamatsu I, Nakahara R, et al
   Segmentectomy versus lobectomy for solid predominant cN0 lung cancer considering Deauville score.
   Eur J Cardiothorac Surg. 2021 Nov 11. pii: 6425616. doi: 10.1093.
   PubMed    
   
   
   
5. GRYSZKO GM, Cackowski MM, Zbytniewski M, Woznica K, et al
   The impact of left lower paratracheal (4L) lymph node dissection on survival in patients with surgically treated left-sided NSCLC.
   Eur J Cardiothorac Surg. 2021;60:1201-1209.
   PubMed     Abstract available
   
   
   
6. DENG C, Zhang Y, Fu F, Ma X, et al
   Genetic-pathological prediction for timing and site-specific recurrence pattern in resected lung adenocarcinoma.
   Eur J Cardiothorac Surg. 2021;60:1223-1231.
   PubMed     Abstract available
   
   
   
7. CABANERO A, Cavestany C, Fra S, Munoz G, et al
   Mediastinal lymph node dissection: punishment or discipline?
   Eur J Cardiothorac Surg. 2021;60:1242-1243.
   PubMed    
   
   
   October 2021
8. ISAKA T, Ito H, Nakayama H, Yokose T, et al
   Impact of the initial site of recurrence on prognosis after curative surgery for primary lung cancer.
   Eur J Cardiothorac Surg. 2021 Oct 23. pii: 6408981. doi: 10.1093.
   PubMed     Abstract available
   
   
   
9. XU L, Yan HJ, Tian D
   Prediction model of lymph node metastases for lung adenocarcinoma: increased applicability of this modeldouble dagger.
   Eur J Cardiothorac Surg. 2021;60:1007-1008.
   PubMed    
   
   
   
10. KAGIMOTO A, Tsutani Y, Mimae T, Miyata Y, et al
    Segmentectomy versus lobectomy for solid predominant cN0 lung cancer: analysis using visual evaluation of positron emission tomography.
    Eur J Cardiothorac Surg. 2021 Oct 14. pii: 6396284. doi: 10.1093.
    PubMed     Abstract available
    
    
    
11. DELL'AMORE A, Lomangino I, Cannone G, Terzi S, et al
    Comparison of operative and postoperative characteristics and outcomes between thoracoscopic segmentectomy and lobectomy for non-small-cell lung cancer: a propensity score matching study from the Italian VATS Group Registry.
    Eur J Cardiothorac Surg. 2021 Oct 13. pii: 6395268. doi: 10.1093.
    PubMed     Abstract available
    
    
    September 2021
12. GOSSOT D
    Lobar or sublobar resection for early-stage lung cancer: at the crossroads.
    Eur J Cardiothorac Surg. 2021 Sep 21. pii: 6373496. doi: 10.1093.
    PubMed    
    
    
    
13. TANE S, Nishikubo M, Kitazume M, Fujibayashi Y, et al
    Cluster analysis of emphysema for predicting pulmonary complications after thoracoscopic lobectomy.
    Eur J Cardiothorac Surg. 2021;60:607-613.
    PubMed     Abstract available
    
    
    August 2021
14. MENNECIER B, Olland A, Mascaux C, Falcoz PE, et al
    Re: Two centres' experience with lung cancer resection in patients with advanced non-small-cell lung cancer following treatment with immune checkpoint inhibitors: safety and clinical outcomes.
    Eur J Cardiothorac Surg. 2021 Aug 26. pii: 6357858. doi: 10.1093.
    PubMed    
    
    
    
15. HOEIJMAKERS F, Hartemink KJ, Verhagen AF, Steup WH, et al
    Variation in incidence, prevention and treatment of persistent air leak after lung cancer surgery.
    Eur J Cardiothorac Surg. 2021 Aug 19. pii: 6354830. doi: 10.1093.
    PubMed     Abstract available
    
    
    
16. FALCOZ PE
    The prognostic value of lymph node ratio in patients with surgically resected stage I-III small-cell lung cancer: a propensity score matching analysis of the SEER database.
    Eur J Cardiothorac Surg. 2021 Aug 11. pii: 6348064. doi: 10.1093.
    PubMed    
    
    
    
17. LUCCHI M, Aprile V
    Not one less, the role of 4L in left-sided lung cancer: the message from the Polish experience.
    Eur J Cardiothorac Surg. 2021 Aug 11. pii: 6348067. doi: 10.1093.
    PubMed    
    
    
    
18. STAMATIS G, Muller S, Weinreich G, Schwarz B, et al
    Significantly favourable outcome for patients with non-small-cell lung cancer stage IIIA/IIIB and single-station persistent N2 (skip or additionally N1) disease after multimodality treatment.
    Eur J Cardiothorac Surg. 2021 Aug 9. pii: 6345854. doi: 10.1093.
    PubMed     Abstract available
    
    
    
19. MERCIER O, Barlesi F
    Precision follow-up for resected non-small-cell lung cancer: is it ready for prime time?
    Eur J Cardiothorac Surg. 2021 Aug 4. pii: 6339783. doi: 10.1093.
    PubMed    
    
    
    
20. HELMINEN O, Soderstrom J, Andersen H, Sihvo E, et al
    How often segmentectomy is feasible in lung cancer surgery: a population-based evaluation.
    Eur J Cardiothorac Surg. 2021 Aug 4. pii: 6339790. doi: 10.1093.
    PubMed     Abstract available
    
    
    July 2021
21. BEATTIE R, Furrer K, Dolan DP, Curioni-Fontecedro A, et al
    Two centres experience of lung cancer resection in patients with advanced non-small cell lung cancer upon treatment with immune checkpoint inhibitors: safety and clinical outcomes.
    Eur J Cardiothorac Surg. 2021 Jul 31. pii: 6332634. doi: 10.1093.
    PubMed     Abstract available
    
    
    
22. XU ZJ, Lin YD
    Reply to Zhang et al.
    Eur J Cardiothorac Surg. 2021;60:440.
    PubMed    
    
    
    
23. KITAHARA H, Shoji F, Akamine T, Kinoshita F, et al
    Preoperative prognostic nutritional index level is associated with tumour-infiltrating lymphocyte status in patients with surgically resected lung squamous cell carcinoma.
    Eur J Cardiothorac Surg. 2021;60:393-401.
    PubMed     Abstract available
    
    
    
24. JONES DR
    Neoadjuvant immunochemotherapy in surgically resectable non-small-cell lung cancer: surgical expertise required.
    Eur J Cardiothorac Surg. 2021;60:88-90.
    PubMed    
    
    
    
25. BERTOLACCINI L, Spaggiari L
    The land of the Lotus-eaters in the COVID-19 epidemic.
    Eur J Cardiothorac Surg. 2021;60:1-2.
    PubMed    
    
    
    
26. GOOSEMAN MR, Falcoz PE, Decaluwe H, Szanto Z, et al
    Morbidity and mortality of lung resection candidates defined by the American College of Chest Physicians as 'moderate risk': an analysis from the European Society of Thoracic Surgeons database.
    Eur J Cardiothorac Surg. 2021;60:91-97.
    PubMed     Abstract available
    
    
    
27. AOKAGE K, Suzuki K, Wakabayashi M, Mizutani T, et al
    Predicting pathological lymph node status in clinical stage IA peripheral lung adenocarcinoma.
    Eur J Cardiothorac Surg. 2021;60:64-71.
    PubMed     Abstract available
    
    
    
28. CHENESSEAU J, Mitilian D, Sharma G, Mussot S, et al
    Superior vena cava prosthetic replacement for non-small cell lung cancer: is it worthwhile?
    Eur J Cardiothorac Surg. 2021 Jul 1. pii: 6312872. doi: 10.1093.
    PubMed     Abstract available
    
    
    
29. YANG H, Mei T
    The prognostic value of lymph node ratio in patients with surgically resected stage I-III small-cell lung cancer: a propensity score matching analysis of the SEER database.
    Eur J Cardiothorac Surg. 2021 Jul 1. pii: 6311990. doi: 10.1093.
    PubMed     Abstract available
    
    
    June 2021
30. NOJIRI T, Inoue M, Maeda H, Takeuchi Y, et al
    Retraction to 'Low-dose human atrial natriuretic peptide for the prevention of postoperative cardiopulmonary complications in chronic obstructive pulmonary disease patients undergoing lung cancer surgery'.
    Eur J Cardiothorac Surg. 2021;59:1352.
    PubMed    
    
    
    
31. MARIANI AW, Vallilo CC, de Albuquerque ALP, Salge JM, et al
    Preoperative evaluation for lung resection in patients with bronchiectasis: should we rely on standard lung function evaluation?
    Eur J Cardiothorac Surg. 2021;59:1272-1278.
    PubMed     Abstract available
    
    
    
32. ZHAO M, Deng J, Wang T, Li Y, et al
    Impact of computed tomography window settings on clinical T classifications and prognostic evaluation of patients with subsolid nodules.
    Eur J Cardiothorac Surg. 2021;59:1295-1303.
    PubMed     Abstract available
    
    
    
33. FALCOZ PE, Olland A, Charloux A
    Does functional evaluation before lung cancer surgery need reappraisal?
    Eur J Cardiothorac Surg. 2021 Jun 11. pii: 6296136. doi: 10.1093.
    PubMed    
    
    
    May 2021
34. XIE D, Zhong Y, Deng J, She Y, et al
    Comparison of uniportal video-assisted thoracoscopic versus thoracotomy bronchial sleeve lobectomy with pulmonary arterioplasty for centrally located non-small-cell lung cancer.
    Eur J Cardiothorac Surg. 2021;59:978-986.
    PubMed     Abstract available
    
    
    
35. SHEN H, Wang X, Nie Y, Zhang K, et al
    Minimally invasive surgery versus thoracotomy for resectable stage II and III non-small-cell lung cancers: a systematic review and meta-analysis.
    Eur J Cardiothorac Surg. 2021;59:940-950.
    PubMed     Abstract available
    
    
    
36. GONZALEZ M, Brunelli A, Szanto Z, Passani S, et al
    Report from the European Society of Thoracic Surgeons database 2019: current surgical practice and perioperative outcomes of pulmonary metastasectomy.
    Eur J Cardiothorac Surg. 2021;59:996-1003.
    PubMed     Abstract available
    
    
    April 2021
37. KAMIGAICHI A, Tsutani Y, Okada M
    Reply to Zhang et al.
    Eur J Cardiothorac Surg. 2021;59:928.
    PubMed    
    
    
    
38. CASIRAGHI M, Spaggiari L
    Reply to Lampridis.
    Eur J Cardiothorac Surg. 2021;59:926-927.
    PubMed    
    
    
    
39. NAKAGAWA K
    Reply to Ding et al.
    Eur J Cardiothorac Surg. 2021;59:925-926.
    PubMed    
    
    
    
40. KANZAKI R, Nagoya A, Kanou T, Ose N, et al
    Risk factors for non-cancer death after surgery in patients with stage I non-small-cell lung cancer.
    Eur J Cardiothorac Surg. 2021;59:633-640.
    PubMed     Abstract available
    
    
    
41. VAN RAEMDONCK D, Treasure T, Van Cutsem E, Macbeth F, et al
    Pulmonary Metastasectomy in Colorectal Cancer: has the randomized controlled trial brought enough reliable evidence to convince believers in metastasectomy to reconsider their oncological practice?
    Eur J Cardiothorac Surg. 2021;59:517-521.
    PubMed    
    
    
    
42. WANG Z, Yang H, Hao X, Zhou J, et al
    Prognostic significance of the N1 classification pattern: a meta-analysis of different subclassification methods.
    Eur J Cardiothorac Surg. 2021;59:545-553.
    PubMed     Abstract available
    
    
    
43. XIE D, Wu J, Hu X, Gonzalez-Rivas D, et al
    Uniportal versus multiportal video-assisted thoracoscopic surgery does not compromise the outcome of segmentectomy.
    Eur J Cardiothorac Surg. 2021;59:650-657.
    PubMed     Abstract available
    
    
    
44. ZHONG Y, Xu Y, Deng J, Wang T, et al
    Prognostic impact of tumour spread through air space in radiological subsolid and pure solid lung adenocarcinoma.
    Eur J Cardiothorac Surg. 2021;59:624-632.
    PubMed     Abstract available
    
    
    March 2021
45. ROMERO ROMAN A, Campo-Canaveral de la Cruz JL, Macia I, Escobar Campuzano I, et al
    Outcomes of surgical resection after neoadjuvant chemoimmunotherapy in locally advanced stage IIIA non-small-cell lung cancer.
    Eur J Cardiothorac Surg. 2021 Mar 1. pii: 6154485. doi: 10.1093.
    PubMed     Abstract available
    
    
    February 2021
46. PARK S, Kim HJ, Park IK, Kim YT, et al
    Stereotactic ablative radiotherapy versus surgery in older patients with stage I lung cancer.
    Eur J Cardiothorac Surg. 2021 Feb 28. pii: 6154725. doi: 10.1093.
    PubMed     Abstract available
    
    
    
47. TING YC, Chuang LC, Hsu PK
    Primary lung cancer in the azygos lobe.
    Eur J Cardiothorac Surg. 2021 Feb 24. pii: 6148899. doi: 10.1093.
    PubMed    
    
    
    
48. THOMAS PA
    Development of radiomics models to predict lymph node metastasis and de-escalated non-small-cell lung cancer surgery: a word of caution.
    Eur J Cardiothorac Surg. 2021 Feb 1. pii: 6125357. doi: 10.1093.
    PubMed    
    
    
    January 2021
49. PETERSEN RH, Huang L, Kehlet H
    Guidelines for enhanced recovery after lung surgery: need for re-analysis.
    Eur J Cardiothorac Surg. 2021;59:291-292.
    PubMed    
    
    
    
50. WALLER DA, Opitz I, Bueno R, Van Schil P, et al
    Divided by an ocean of water but united in an ocean of uncertainty: a transatlantic review of mesothelioma surgery guidelines.
    Eur J Cardiothorac Surg. 2021;59:8-11.
    PubMed    
    
    
    December 2020
51. ABID W, Seguin-Givelet A, Brian E, Grigoroiu M, et al
    Second pulmonary resection for a second primary lung cancer: analysis of morbidity and survival.
    Eur J Cardiothorac Surg. 2020 Dec 24. pii: 6046581. doi: 10.1093.
    PubMed     Abstract available
    
    
    
52. WU H, Jin R, Yang S, Park BJ, et al
    Long-term and short-term outcomes of robot- versus video-assisted anatomic lung resection in lung cancer: a systematic review and meta-analysis.
    Eur J Cardiothorac Surg. 2020 Dec 23. pii: 6046142. doi: 10.1093.
    PubMed     Abstract available
    
    
    
53. BAIG MZ, Razi SS, Stroever S, Weber JF, et al
    Anatomic resection has superior long-term survival compared with wedge resection for second primary lung cancer after prior lobectomy.
    Eur J Cardiothorac Surg. 2020 Dec 17. pii: 6041053. doi: 10.1093.
    PubMed     Abstract available
    
    
    
54. ZHANG X, Dong W, Zhang L
    Segmentectomy for radiologically aggressive small-sized lung cancer: one size fits all?
    Eur J Cardiothorac Surg. 2020 Dec 6. pii: 6126780. doi: 10.1093.
    PubMed    
    
    
    November 2020
55. BOUABDALLAH I, Pauly V, Viprey M, Orleans V, et al
    Unplanned readmission and survival after video-assisted thoracic surgery and open thoracotomy in patients with non-small-cell lung cancer: a 12-month nationwide cohort study.
    Eur J Cardiothorac Surg. 2020 Nov 25. pii: 6000651. doi: 10.1093.
    PubMed     Abstract available
    
    
    
56. TRICARD J, Milad D, Chermat A, Simard S, et al
    Staged management of cardiac disease and concomitant early lung cancer: a 20-year single-center experience.
    Eur J Cardiothorac Surg. 2020 Nov 19. pii: 5990294. doi: 10.1093.
    PubMed     Abstract available
    
    
    
57. LAMPRIDIS S
    The role of surgery in oligometastatic non-small-cell lung cancer.
    Eur J Cardiothorac Surg. 2020 Nov 17. pii: 5983874. doi: 10.1093.
    PubMed    
    
    
    
58. WANG Y, Qian F, Hu M, Chen Y, et al
    Clinical significance of visceral pleural and lymphovascular invasion in surgically resected adenosquamous lung cancer.
    Eur J Cardiothorac Surg. 2020 Nov 17. pii: 5983876. doi: 10.1093.
    PubMed     Abstract available
    
    
    
59. FUJIBAYASHI Y, Ogawa H, Kitazume M, Nishikubo M, et al
    Pleural invasion, epidermal growth factor receptor mutation and carcinoembryonic antigen level affect pleural lavage cytology-positive status in non-small-cell lung cancer.
    Eur J Cardiothorac Surg. 2020 Nov 16. pii: 5983731. doi: 10.1093.
    PubMed     Abstract available
    
    
    
60. DING Q, Shu J, Xu X, Chen Y, et al
    Clinical implications of the pattern of recurrence of pN2 non-small-cell lung cancer.
    Eur J Cardiothorac Surg. 2020 Nov 16. pii: 5983729. doi: 10.1093.
    PubMed    
    
    
    
61. ABUGHARARAH TZ, Jeong YH, Alabbood F, Chong Y, et al
    Lobe-specific lymph node dissection in stage IA non-small-cell lung cancer: a retrospective cohort study.
    Eur J Cardiothorac Surg. 2020 Nov 5. pii: 5956254. doi: 10.1093.
    PubMed     Abstract available
    
    
    
62. CHANG SH, Zervos M, Kent A, Chachoua A, et al
    Safety of patients and providers in lung cancer surgery during the COVID-19 pandemic.
    Eur J Cardiothorac Surg. 2020 Nov 5. pii: 5956370. doi: 10.1093.
    PubMed     Abstract available
    
    
    
63. HOYOS MEJIA L, Romero Roman A, Gil Barturen M, Cordoba Pelaez MDM, et al
    Thoracic surgery during the coronavirus disease 2019 (COVID-19) pandemic in Madrid, Spain: single-centre report.
    Eur J Cardiothorac Surg. 2020;58:991-996.
    PubMed     Abstract available
    
    
    October 2020
64. POMPILI C, McLennan Battleday F, Chia WL, Chaudhuri N, et al
    Poor preoperative quality of life predicts prolonged hospital stay after VATS lobectomy for lung cancer.
    Eur J Cardiothorac Surg. 2020 Oct 15. pii: 5923779. doi: 10.1093.
    PubMed     Abstract available
    
    
    September 2020
65. KARIM HMR, Bhakta P, Esquinas AM
    An enquiry to Choi et al.'s surgical outcome and prognosis of lung cancer in patients with chronic lung disease.
    Eur J Cardiothorac Surg. 2020 Sep 28. pii: 5912545. doi: 10.1093.
    PubMed    
    
    
    
66. KAMIGAICHI A, Tsutani Y, Mimae T, Miyata Y, et al
    Prognosis of segmentectomy and lobectomy for radiologically aggressive small-sized lung cancer.
    Eur J Cardiothorac Surg. 2020 Sep 7. pii: 5902140. doi: 10.1093.
    PubMed     Abstract available
    
    
    
67. NA KJ, Park S, Lee HJ, Park IK, et al
    Comparison between lung perfusion scan and single-photon emission computed tomography/computed tomography for predicting postoperative lung function after pulmonary resection in patients with borderline lung function.
    Eur J Cardiothorac Surg. 2020 Sep 3. pii: 5900864. doi: 10.1093.
    PubMed     Abstract available
    
    
    
68. GONFIOTTI A, Gatteschi L, Salvicchi A, Bongiolatti S, et al
    Clinical courses and outcomes of five patients with primary lung cancer surgically treated while affected by Severe acute respiratory syndrome coronavirus 2.
    Eur J Cardiothorac Surg. 2020;58:598-604.
    PubMed     Abstract available
    
    
    
69. MA H, Zhang G
    How to treat early-stage lung adenocarcinoma based on the size of the clinical solid component?
    Eur J Cardiothorac Surg. 2020;58:662.
    PubMed    
    
    
    
70. HAN SJ, Jeon JH
    Reply to Ma and Zhang.
    Eur J Cardiothorac Surg. 2020;58:662-663.
    PubMed    
    
    
    August 2020
71. CORSINI EM, Weissferdt A, Pataer A, Zhou N, et al
    Pathological nodal disease defines survival outcomes in patients with lung cancer with tumour major pathological response following neoadjuvant chemotherapy.
    Eur J Cardiothorac Surg. 2020 Aug 30. pii: 5899328. doi: 10.1093.
    PubMed     Abstract available
    
    
    
72. FIORELLI S, Massullo D, Ibrahim M, Piccioni F, et al
    Perspectives in surgical and anaesthetic management of lung cancer in the era of coronavirus disease 2019 (COVID-19).
    Eur J Cardiothorac Surg. 2020 Aug 26. pii: 5897205. doi: 10.1093.
    PubMed     Abstract available
    
    
    
73. CHIAPPETTA M, Lococo F, Leuzzi G, Sperduti I, et al
    External validation of the N descriptor in the proposed tumour-node-metastasis subclassification for lung cancer: the crucial role of histological type, number of resected nodes and adjuvant therapy.
    Eur J Cardiothorac Surg. 2020 Aug 8. pii: 5885289. doi: 10.1093.
    PubMed     Abstract available
    
    
    
74. YANG HX, Yang MZ
    Reply to Deng et al. and Zhang et al.
    Eur J Cardiothorac Surg. 2020;58:405-406.
    PubMed    
    
    
    
75. HENNON MW, DeGraaff LH, Demmy TL, Yendamuri S, et al
    Reply to Maier et al.
    Eur J Cardiothorac Surg. 2020;58:403-404.
    PubMed    
    
    
    
76. MAIER H, Ng C, Kroepfl V, Augustin F, et al
    Time to rethink the concept of nodal upstaging.
    Eur J Cardiothorac Surg. 2020;58:403.
    PubMed    
    
    
    
77. MELEK H, Ozer E, Bayram AS, Gebitekin C, et al
    Reply to Lococo et al.
    Eur J Cardiothorac Surg. 2020;58:407-408.
    PubMed    
    
    
    
78. WINCKELMANS T, Decaluwe H, De Leyn P, Van Raemdonck D, et al
    Reply to Deng and Tang.
    Eur J Cardiothorac Surg. 2020;58:406-407.
    PubMed    
    
    
    July 2020
79. NAKAGAWA K, Yoshida Y, Yotsukura M, Watanabe SI, et al
    Pattern of recurrence of pN2 non-small-cell lung cancer: should postoperative radiotherapy be reconsidered?
    Eur J Cardiothorac Surg. 2020 Jul 30. pii: 5878241. doi: 10.1093.
    PubMed     Abstract available
    
    
    
80. TEN BERGE MG, Beck N, Steup WH, Verhagen AFTM, et al
    Textbook outcome as a composite outcome measure in non-small-cell lung cancer surgery.
    Eur J Cardiothorac Surg. 2020 Jul 30. pii: 5878242. doi: 10.1093.
    PubMed     Abstract available
    
    
    May 2020
81. WU D, Liang H, Liang W, Liu H, et al
    Spontaneous ventilation video-assisted thoracoscopic surgery for patients with non-small-cell lung cancer with excess body weight.
    Eur J Cardiothorac Surg. 2020 May 23. pii: 5843501. doi: 10.1093.
    PubMed     Abstract available
    
    
    
82. ZHAO M, Deng J, She Y, Chen C, et al
    Prognostic impact of solid-part tumour volume doubling time: is it still valuable in the subgroup of patients with part-solid nodules?
    Eur J Cardiothorac Surg. 2020;57:1013.
    PubMed    
    
    
    
83. SHIMADA Y, Setojima Y, Ikeda N
    Reply to Zhao et al.
    Eur J Cardiothorac Surg. 2020;57:1013-1014.
    PubMed    
    
    
    April 2020
84. VAN DORP M, Beck N, Steup WH, Schreurs WH, et al
    Surgical treatment of pulmonary metastases in the Netherlands: data from the Dutch Lung Cancer Audit for Surgery.
    Eur J Cardiothorac Surg. 2020 Apr 13. pii: 5819620. doi: 10.1093.
    PubMed     Abstract available
    
    
    
85. BOCCHIALINI G, Lagrasta C, Madeddu D, Mazzaschi G, et al
    Spatial architecture of tumour-infiltrating lymphocytes as a prognostic parameter in resected non-small-cell lung cancer.
    Eur J Cardiothorac Surg. 2020 Apr 8. pii: 5817917. doi: 10.1093.
    PubMed     Abstract available
    
    
    
86. HINO H, Saito T, Matsui H, Taniguchi Y, et al
    Utility of Geriatric Nutritional Risk Index in patients with lung cancer undergoing surgery.
    Eur J Cardiothorac Surg. 2020 Apr 1. pii: 5814344. doi: 10.1093.
    PubMed     Abstract available
    
    
    March 2020
87. DENG HY, Wang T, Tang X
    Should the left lower paratracheal lymph node always be dissected in patients with left-sided lung cancer?
    Eur J Cardiothorac Surg. 2020 Mar 26. pii: 5811876. doi: 10.1093.
    PubMed    
    
    
    
88. ZHANG X, Jiang Y, Zhang L
    L4 lymph node dissection in left-side operable non-small-cell lung cancer: one size fits all?
    Eur J Cardiothorac Surg. 2020 Mar 25. pii: 5811875. doi: 10.1093.
    PubMed    
    
    
    
89. HANDA Y, Tsutani Y, Okada M
    Reply to Li and Che.
    Eur J Cardiothorac Surg. 2020;57:614-615.
    PubMed    
    
    
    September 2019
90. CHEN C, Zhang X, Gu C, Wang Y, et al
    Surgery performed at night by continuously working surgeons contributes to a higher incidence of intraoperative complications in video-assisted thoracoscopic pulmonary resection: a large monocentric retrospective study.
    Eur J Cardiothorac Surg. 2019 Sep 20. pii: 5572143. doi: 10.1093.
    PubMed     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Lung Cancer is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: